From April 1, 2023 to May 12, 2023, the company has repurchased 0 shares, representing 0% for ¥0 million. With this, the company has completed the repurchase of 263,900 shares, representing 0.6% for ¥545.29 million under the buyback announced on May 11, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,000 JPY | +0.65% | +2.04% | -0.84% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.84% | 557M | |
+16.16% | 41.97B | |
+22.56% | 22.34B | |
+16.08% | 15.25B | |
+16.26% | 14B | |
+49.16% | 12.06B | |
-10.77% | 6.8B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.18% | 5.49B |
- Stock Market
- Equities
- 4559 Stock
- News Zeria Pharmaceutical Co., Ltd.
- Tranche Update on Zeria Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2022.